Latest Close
$5.38
Stock Hub
AARD
Aardvark Therapeutics, Inc.
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. Use the sections below to move between chart, technical analysis, fundamentals, and news.
1y Change
-$5.51 (-50.60%)
Market Cap
$117,740,472.00
Sector
Healthcare
Industry
Biotechnology
Recommendation
buy
52W Range
$3.35 to $17.94
Target Mean Price
$11.11
Beta
Not available
Trailing P/E
Not available
Forward P/E
-1.93
Price / Book
1.57
Company Overview
Aardvark Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on developing small-molecule therapeutics to activate innate homeostatic pathways for the treatment of metabolic diseases. Aardvark Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.